Mon, August 8, 2022
Fri, August 5, 2022
Thu, August 4, 2022

Andrew Berens Maintained (AGIO) at Buy with Increased Target to $37 on, Aug 5th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-37-on-aug-5th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $33 to $37 on, Aug 5th, 2022.

Andrew has made no other calls on AGIO in the last 4 months.



There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Salveen Richter of "Goldman Sachs" Maintained at Strong Sell with Decreased Target to $16 on, Tuesday, May 24th, 2022

Publication Contributing Sources